Three leading researchers from the Mount Sinai Health System discuss how ketamine, cannabis, and ecstasy are being used (or studied) to treat everything from severe depression to addiction to PTSD. We discuss the upsides, downsides, and regulatory puzzles.
Jan 23
660. The Wellness Industry Is Gigantic — and Mostly Wrong
Zeke Emanuel (a physician, medical ethicist, and policy wonk) has some different ideas for how to lead a healthy and meaningful life. It starts with ice cream. (Part three of “The Freakonomics Radio Guide to Getting Better.”) SOURCES:Zeke Emanuel, oncologist, bioethicist, profess ... Show More
1h 5m
Jan 21
Steve Levitt Quits His Podcast, Joins Ours
After five years, Levitt is ending People I (Mostly) Admire, and will start hosting the occasional Freakonomics Radio episode. We couldn’t be happier. SOURCES:Steve Levitt, co-author of Freakonomics and host of People I (Mostly) Admire. RESOURCES:"How to Help Kids Succeed," by Pe ... Show More
45m 58s
Jan 16
659. Can Marty Makary Fix the F.D.A.?
It regulates 20 percent of the U.S. economy, and its commissioner has an aggressive agenda — faster drug approvals, healthier food, cures for diabetes and cancer. How much can he deliver? (Part two of “The Freakonomics Radio Guide to Getting Better.”) SOURCES:Marty Makary, commis ... Show More
55m 25s
Nov 2020
The future of psychedelic-assisted psychotherapy | Rick Doblin
Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising. In this fascinating dive into the science of psychedelics, he explains how drugs like LSD, psilocy ... Show More
14m 50s
Oct 2022
Psychedelics & Neurostimulation for Brain Rewiring | Dr. Nolan Williams
In this episode, my guest is Nolan Williams, M.D., a triple board-certified psychiatrist, neurologist and professor of psychiatry and behavioral sciences at Stanford School of Medicine. He is also the Director of the Stanford Brain Stimulation Lab. We discuss clinical application ... Show More
2h 44m
May 2023
How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks
In this episode, I discuss what psilocybin is (chemically) and how it works at the cellular and neural circuit level to trigger neuroplasticity, which is our brain’s ability to rewire itself in ways that lead to long-lasting shifts in our emotional, cognitive and behavioral patte ... Show More
2h 5m
Dec 2019
#177 — Psychedelic Science
<p>Sam Harris speaks with Roland Griffiths about the current state of research on psychedelics. They discuss the historical prohibition against their use; the clinical and scientific promise of psilocybin, mescaline, LSD, DMT, MDMA, and other compounds; the risks associated with ... Show More
1h 26m